Twenty-one patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa pneumonia were treated with nebulized polymyxin E (colistin). Overall clinical and microbiological ...
Am J Health Syst Pharm. 2005;62(1):39-47. The inhaled dose most often administered in our study was 0.5 MU every eight hours. The fill volume for the nebulizer (Cirrus, Intersurgical, Wokingham, UK) ...
Editor's note: Nosocomial pneumonia is a common and potentially lethal complication for patients being treated in intensive care units (ICUs). Studies indicate that up to 27% of patients admitted to ...
The European Medicines Agency (EMA) has reviewed the safety and effectiveness of products containing the antibiotics colistin or colistimethate sodium (known as polymyxins) and recommended changes to ...
A new study has found that the majority of residents in a rural village of Vietnam harbored multi-drug-resistant (MDR), colistin-resistant E. coli bacteria. Colistin is typically used as a last-resort ...
Please provide your email address to receive an email when new articles are posted on . Enterobacteriaceae carrying a gene conferring transmissible polymyxin resistance have been identified and ...
Colistin is used as last-resort treatment for bacterial infections Provectus’ RBS effectively inhibits growth of colistin-resistant G- bacteria RBS also possesses rapid-killing feature The article, ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback